Antisense oligonucleotides work by binding to messenger RNA (mRNA), which stops the production of proteins present in the mRNA. They have gained popularity in treating rare genetic diseases such as spinal muscular atrophy, cardiovascular diseases, and cancer. The market growth is driven by rising investment in research and development for therapeutics discovery and development of novel...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian